Thirumalai Chemicals Limited — Others, 07-07-2025: Corrigendum

Thirumalai Chemicals has announced a board meeting on July 14, 2025, to seek shareholders’ approval for a preferential issue of equity shares aggregating ₹450.62 Cr. The proceeds will primarily fund a ₹330 Cr investment in TCL Global BV for capital expenditure in its US subsidiary, TCL Specialties LLC, with the balance allocated to general corporate purposes (₹110.62 Cr) and issue expenses (₹10 Cr). The issue price of ₹277 per share is based on regulatory pricing guidelines and an independent valuation of ₹270.94 per share. An addendum correcting shareholding data in the valuation report has also been issued.